Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

The 10 most innovative biotech companies of 2025 are leveraging AI ... and the basis of drugs including insulin and obesity medications like Wegovy and Zepbound. Because peptides are potent ...

This began a revolution in molecule production that culminated in the founding of Genentech, the first publicly-owned biotech company ... a human-based form of insulin that dramatically increased ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

Novo Nordisk has acquired UK start-up Ziylo in a deal worth up to $800m in a bid to develop the world’s first “smart” insulin ... spun out of Ziylo to a new company, Carbometrics.

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...